Dowling & Yahnke’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-30,000	Closed	-$483K	–	273
2014 Q1	$483K	Sell	30,000 -22,957	-43%	-$370K	0.06%	195
2013 Q4	$495K	Hold	52,957	–	–	0.07%	188
2013 Q3	$599K	Hold	52,957	–	–	0.09%	166
2013 Q2	$709K	Buy	+52,957	New	+$709K	0.12%	156